日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Phase II study of maintenance trifluridine/tipiracil (TAS-102) plus bevacizumab after induction chemotherapy in metastatic colorectal cancer

转移性结直肠癌诱导化疗后维持治疗三氟尿苷/替吡嘧啶（TAS-102）联合贝伐单抗的II期研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyag067
Ota, Katsuya; Uemura, Mamoru; Tanida, Tsukasa; Nakata, Ken; Kudo, Toshihiro; Kagawa, Yoshinori; Haraguchi, Naotsugu; Minami, Soichiro; Matsuura, Yusuke; Ota, Hirofumi; Hiraki, Masayuki; Yasui, Masayoshi; Takahashi, Hidekazu; Iwamoto, Kazuya; Nishida, Naohiro; Hata, Taishi; Nishizawa, Yujiro; Fukunaga, Mutsumi; Komori, Takamichi; Takahashi, Yusuke; Tokuyama, Shinji; Tamagawa, Hiroshi; Naito, Atsushi; Yoshihara, Terukazu; Suzuki, Rei; Sugimoto, Satoshi; Miyake, Masakazu; Takiguchi, Nobuo; Tei, Mitsuyoshi; Tamai, Koki; Fukada, Akio; Ogino, Takayuki; Miyoshi, Norikatsu; Satoh, Taroh; Yamamoto, Hirofumi; Murata, Kohei; Doki, Yuichiro; Eguchi, Hidetoshi
肿瘤
肠癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial

在BRAF V600E/R突变或非V600 BRAF突变的晚期实体瘤患者中，达拉非尼和曲美替尼联合用药的疗效评价（BELIEVE，NCCH1901）：一项多中心、开放标签、单臂II期临床试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2024.102447
Shimoi, Tatsunori; Sunami, Kuniko; Tahara, Makoto; Nishiwaki, Satoshi; Tanaka, Shota; Baba, Eishi; Kanai, Masashi; Kinoshita, Ichiro; Shirota, Hidekazu; Hayashi, Hideyuki; Nishida, Naohiro; Kubo, Toshio; Mamesaya, Nobuaki; Ando, Yayoi; Okita, Natsuko; Shibata, Taro; Nakamura, Kenichi; Yamamoto, Noboru
BRAF
发表日期：2024
文献求助 收藏

Early detection of brain metastases and appropriate local therapy followed by systemic chemotherapy may improve the prognosis of gastric cancer

早期发现脑转移并进行适当的局部治疗，随后辅以全身化疗，可能改善胃癌的预后。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-46933-z
Ishizuka, Yasunobu; Omori, Takeshi; Shinno, Naoki; Yamamoto, Masaaki; Hara, Hisashi; Otsuka, Tomoyuki; Nishio, Minako; Nishida, Naohiro; Fujisawa, Fumie; Sugimoto, Naotoshi; Yagi, Toshinari; Goto, Masahiro; Nishikawa, Hiroki; Kudo, Toshihiro
胃癌
肿瘤
肿瘤免疫
神经科学
发表日期：2023
文献求助 收藏

Clinical outcomes of neoadjuvant chemotherapy for resectable colorectal liver metastasis with intermediate risk of postoperative recurrence: A multi-institutional retrospective study

新辅助化疗治疗术后复发风险中等的可切除结直肠癌肝转移的临床疗效：一项多中心回顾性研究

期刊:Annals of Gastroenterological Surgery
影响因子:3.3
doi:10.1002/ags3.12631
Noda, Takehiro; Takahashi, Hidekazu; Tei, Mitsuyoshi; Nishida, Naohiro; Hata, Taishi; Takeda, Yutaka; Ohue, Masayuki; Wada, Hiroshi; Mizushima, Tsunekazu; Asaoka, Tadafumi; Uemura, Mamoru; Kobayashi, Shogo; Murata, Kohei; Satoh, Taroh; Doki, Yuichiro; Eguchi, Hidetoshi
肿瘤
肠癌
肿瘤免疫
发表日期：2023
文献求助 收藏

Combination Therapy With S-1, Oxaliplatin and Leucovorin in Patients With Advanced Esophageal Squamous Cell Carcinoma

S-1、奥沙利铂和亚叶酸钙联合治疗晚期食管鳞状细胞癌

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.11730
Nishida, Naohiro; Yamsaki, Makoto; Odagiri, Kazuki; Yamashita, Kotaro; Tanaka, Koji; Sakai, Daisuke; Makino, Tomoki; Takahashi, Tsuyoshi; Kurokawa, Yukinori; Satoh, Taroh; Mori, Masaki; Doki, Yuichiro
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis

生存率分析预测一碳叶酸代谢酶作为抗癌靶点

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-017-18456-x
Koseki, Jun; Konno, Masamitsu; Asai, Ayumu; Colvin, Hugh; Kawamoto, Koichi; Nishida, Naohiro; Sakai, Daisuke; Kudo, Toshihiro; Satoh, Taroh; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi
肿瘤
肿瘤免疫
代谢
发表日期：2018
文献求助 收藏

Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells

计算转录组学方法表征了甲基化组学和转录组学的参与情况，并鉴定了胃肠道癌干细胞化疗耐药性的新型治疗靶点。

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-018-19284-3
Konno, Masamitsu; Matsui, Hidetoshi; Koseki, Jun; Asai, Ayumu; Kano, Yoshihiro; Kawamoto, Koichi; Nishida, Naohiro; Sakai, Daisuke; Kudo, Toshihiro; Satoh, Taroh; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi
肿瘤
表观遗传
肿瘤免疫
细胞生物学
干细胞
发育与干细胞
发表日期：2018
文献求助 收藏

The mitochondrial one-carbon metabolic pathway is associated with patient survival in pancreatic cancer

线粒体单碳代谢途径与胰腺癌患者的生存率相关

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2018.8795
Noguchi, Kozo; Konno, Masamitsu; Koseki, Jun; Nishida, Naohiro; Kawamoto, Koichi; Yamada, Daisaku; Asaoka, Tadafumi; Noda, Takehiro; Wada, Hiroshi; Gotoh, Kunihito; Sakai, Daisuke; Kudo, Toshihiro; Satoh, Taroh; Eguchi, Hidetoshi; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi
肿瘤
肿瘤免疫
代谢
线粒体
胰腺癌
发表日期：2018
文献求助 收藏

c-Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer

c-Met 在小鼠胰腺癌模型中影响吉西他滨耐药性

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2018.8793
Noguchi, Kozo; Konno, Masamitsu; Eguchi, Hidetoshi; Kawamoto, Koichi; Mukai, Ryouta; Nishida, Naohiro; Koseki, Jun; Wada, Hiroshi; Akita, Hirofumi; Satoh, Taroh; Marubashi, Shigeru; Nagano, Hiroaki; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi
胰腺癌
肿瘤
肿瘤免疫
发表日期：2018
文献求助 收藏

Cell-free culture conditioned medium elicits pancreatic β cell lineage-specific epigenetic reprogramming in mice

无细胞培养条件培养基可诱导小鼠胰岛β细胞谱系特异性表观遗传重编程。

期刊:Oncology Letters
影响因子:2.2
doi:10.3892/ol.2018.9008
Kawamoto, Koichi; Ohashi, Tomofumi; Konno, Masamitsu; Nishida, Naohiro; Koseki, Jun; Matsui, Hidetoshi; Sakai, Daisuke; Kudo, Toshihiro; Eguchi, Hidetoshi; Satoh, Taroh; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi
Cell Culture
细胞生物学
表观遗传
发表日期：2018
文献求助 收藏